Global Next-Generation Sequencing (NGS) Market

1 INTRODUCTION OF GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL NEXT-GENERATION SEQUENCING (NGS)MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY
5.1 Sequencing By Synthesis
5.2 ION Semiconductor Sequencing
5.3 Single-Molecule Real-Time Sequencing
5.4 Nanopore Sequencing

6 GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION
6.1 Diagnostics
6.2 Drug Discovery
6.3 Biomarker Discovery
6.4 Precision Medicine
6.5 Agriculture & Animal Research
6.6 Other Applications

7 GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET, BY END USER
7.1 Research Centers and Academic & Government Institutes
7.2 Hospitals & Clinics
7.3 Pharmaceutical & Biotechnology Companies
7.4 Other End Users

8 GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT AND SERVICES
8.1 Pre-Sequencing Products & Services Market
8.1.1 Sample Preparation
8.1.1.1 Dna Fragmentation, End Repair, A-Tailing, and Size Selection
8.1.1.2 Library Preparation & Target Enrichment
8.1.1.3 Quality Control
8.2 NGS Platforms, Consumables, & Services for Platforms
8.3 Sequencing Services Market
8.3.1 Targeted Re-Sequencing
8.3.2 Rna-Seq
8.3.3 De Novo Sequencing
8.3.4 Exome Sequencing
8.3.5 Chip-Seq
8.3.6 Whole-Genome Sequencing
8.3.7 Methyl-Seq
8.3.8 Other Applications
8.4 NGS Data Analysis, Storage, and Management (Bioinformatics)
8.4.1 NGS Data Analysis Software & Workbenches
8.4.2 NGS Data Analysis Services
8.4.3 NGS Storage, Management, and Cloud Computing Solutions
9 GLOBAL NEXT-GENERATION SEQUENCING (NGS)MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL NEXT-GENERATION SEQUENCING (NGS)MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Illumina, Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Thermo Fisher Scientific Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Pacific Biosciences of California, Inc.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Qiagen N.V.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Beijing Genomics Institute
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Perkinelmer, Inc
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 F. Hoffmann-La Roche AG
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Agilent Technologies, Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Gatc Biotech AG
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 Oxford Nanopore Technologies, Ltd.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

11.11 Macrogen, Inc.
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments

11.12 Eurofins Scientific
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments

12 Appendix
12.1 Related Reports